Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 179
Filtrar
Más filtros

País/Región como asunto
Intervalo de año de publicación
1.
Endoscopy ; 42(6): 448-55, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20414864

RESUMEN

BACKGROUND AND STUDY AIMS: The determinants of the observed variability of adenoma detection rate (ADR) in endoscopy screening have not yet been fully explained. PATIENTS AND METHODS: Between November 1999 and November 2006 13 764 people (7094 men, 6670 women; age range 55-64) underwent screening flexible sigmoidoscopy at five hospital endoscopy units in Turin. To study the determinants of the ADR for distal adenomas, accounting for patient, examiner, and hospital characteristics, we applied a multivariate multilevel regression model. RESULTS: Average ADRs for all adenomas and for advanced adenomas (size > or = 10 mm, villous component > 20 %, high grade dysplasia) were 13.5 % (range 5.2 %-25.0 %) and 6.4 % (3.1 %-10.7 %) for men, and 8.0 % (2.5 %-14.0 %) and 3.7 % (0.2 % - 7.4 %) for women. In multivariate analysis, increased ADR of advanced adenomas was associated with male gender (odds ratio [OR] 1.78, 95 %CI 1.49 - 2.11), self-report of one first-degree relative with colorectal cancer (CRC) (1.44, 1.11-1.86), or of recent-onset rectal bleeding (1.73, 1.24-2.40). Adjusting for these variables, a significantly lower ADR was found for endoscopists with either a lower rate of incomplete sigmoidoscopy (< 9 %; OR 0.59, 95 %CI 0.41-0.87) or a higher rate (> 12 %; 0.64, 0.45-0.91), or with low activity volume (< 85 sigmoidoscopies/year; 0.66, 0.50-0.86). Residual variability explained by the endoscopy center effect was about 1 % and statistically significant. CONCLUSIONS: Endoscopist performance in flexible sigmoidoscopy CRC screening is highly variable. Low volume of screening activity independently predicts lower ADR, suggesting that operators devoting more time to screening sigmoidoscopy may perform better. Variability among pathologists in adenoma classification might explain part of the residual variability across endoscopy units.


Asunto(s)
Adenoma/diagnóstico , Sigmoidoscopía , Adenoma/patología , Femenino , Humanos , Masculino , Tamizaje Masivo/estadística & datos numéricos , Persona de Mediana Edad , Variaciones Dependientes del Observador , Sigmoidoscopía/estadística & datos numéricos
2.
Aliment Pharmacol Ther ; 25(7): 835-40, 2007 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-17373922

RESUMEN

BACKGROUND: Argon plasma coagulation seems to be a promising technique for ablation of Barrett's oesophagus, yet few long-term efficacy data are available. AIM: To report on a long-term follow-up and the factors that determine the recurrence of intestinal metaplasia in a cohort of patients with non dysplastic, intestinal type Barrett's oesophagus, after complete ablation of the metaplastic mucosa with argon plasma coagulation. METHODS: Ninety-six patients underwent endoscopic argon plasma coagulation with adequate acid suppression obtained through a continuous omeprazole therapy (50 patients) or through laparoscopic fundoplication (46 patients). Complete ablation was achieved in 94 patients who underwent follow-up. Endoscopic and histological examinations were performed every 12 months. RESULTS: The median follow-up of the patients was 36 months (range 18-98). A recurrence of intestinal metaplasia was found in 17 patients (18%), with an annual recurrence rate of 6.1%. Neither dysplasia, nor adenocarcinoma were found during the follow-up. Through the use of logistic regression analysis, previous laparoscopic fundoplication was associated with a reduced recurrence rate of intestinal metaplasia (odds ratio 0.30, 95% confidence interval 0.10-0.93). CONCLUSIONS: The long-term recurrence of intestinal type Barrett's oesophagus was low after complete ablation with argon plasma coagulation. The control of oesophageal acidity acid exposure with laparoscopic fundoplication seems to reduce the recurrence rate.


Asunto(s)
Esófago de Barrett/cirugía , Esófago/patología , Coagulación con Láser/métodos , Adulto , Anciano , Femenino , Estudios de Seguimiento , Humanos , Masculino , Metaplasia , Persona de Mediana Edad , Prevención Secundaria , Resultado del Tratamiento
3.
Diabetes ; 42(11): 1579-87, 1993 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-8405698

RESUMEN

The rate of intestinal absorption of sugars and their site of absorption determine postprandial plasma glucose concentrations. Does chronic consumption of high-carbohydrate, high-fiber, low-fat diets of the type recommended by many diabetes associations induce adaptive changes in transport and metabolism of sugars in the small intestine? Control and STZ-induced diabetic (> 60 days diabetic) mice were fed high-carbohydrate or no-carbohydrate rations for 7 days. Brush-border glucose and fructose uptake per milligram increased 2 times with dietary carbohydrate in both diabetic and control mice; uptake, however, did not differ between diabetic and control mice. Compared with the distal small intestine, glucose uptake per milligram was 2 to 6 times higher in the proximal and middle regions, and enhancement of uptake by diet was limited to these regions. Changes in site density of intestinal glucose transporters as determined by specific phlorizin binding were tightly correlated with changes in brush-border glucose uptake per milligram. There were neither diabetes- nor diet-induced changes in the Kd of specific phlorizin binding, in the amount of glucose absorbed per transporting site, or in passive glucose permeability. Intestinal weights, wt/cm, intestinal length, and mucosal mass increased significantly with diabetes, and sugar transport per centimeter and per small intestine was up to 60% greater in diabetic mice. Dietary carbohydrate stimulated specific sucrase activity in the proximal small intestine of both diabetic and control mice. Chronic diabetes enhances sugar transport by nonspecific increases in intestinal mass.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Carbohidratos/farmacocinética , Diabetes Mellitus Experimental/fisiopatología , Carbohidratos de la Dieta/farmacología , Intestino Delgado/fisiología , Animales , Transporte Biológico/fisiología , Glucemia/análisis , Peso Corporal , Diabetes Mellitus Experimental/metabolismo , Relación Dosis-Respuesta a Droga , Fructosa/farmacocinética , Glucosa/farmacocinética , Hiperplasia/patología , Absorción Intestinal/fisiología , Mucosa Intestinal/metabolismo , Mucosa Intestinal/fisiología , Mucosa Intestinal/ultraestructura , Intestino Delgado/química , Intestino Delgado/embriología , Masculino , Ratones , Microvellosidades/metabolismo , Microvellosidades/fisiología , Microvellosidades/ultraestructura , Proteínas de Transporte de Monosacáridos/análisis , Proteínas de Transporte de Monosacáridos/fisiología , Estreptozocina , Sacarasa/fisiología
4.
Am J Clin Nutr ; 62(3): 540-6, 1995 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-7661115

RESUMEN

The small intestine of obese animals supplies nutrients to a metabolic live mass (body weight 0.75) that is much higher than that of age- and sex-matched lean animals. To determine the mechanisms of adaptation of the small intestine to obesity, we determined the rate of uptake of D-glucose and five amino acids, the site density of intestinal D-glucose transporters, and the permeability of the absorptive mucosa in isolated everted intestinal sleeves of genetically obese male mice (C57BL/6J ob/ob) and their lean male littermates. Intestinal D-glucose, proline, alanine, aspartate, leucine, and lysine uptakes per milligram were each similar in the small intestine of obese and control mice. Mucosal permeability, site density of intestinal D-glucose transporters, and their affinity for phlorizin were also each similar between obese mice and their lean controls. In contrast, intestinal D-glucose, proline, alanine, aspartate, leucine, and lysine uptakes per centimeter of small intestine were each approximately 40% greater in obese mice compared with lean controls (P < 0.001 to P < 0.08, depending on the nutrient and intestinal region). Differences in total absorptive capacity for any nutrient between the small intestine of obese and lean mice reflect mainly differences in intestinal weights. Thus, genetic obesity is associated with increased intestinal growth, which augments absorption of all types of nutrients. The ratio of intestinal absorptive capacity to metabolic mass, and of intestinal mass to metabolic mass, does not change with obesity, indicating that in mice, changes in intestinal mass and in absorptive capacity are directly proportional to changes in metabolic mass.


Asunto(s)
Fenómenos Fisiológicos Nutricionales de los Animales , Intestino Delgado/metabolismo , Obesidad/genética , Obesidad/metabolismo , Aminoácidos/farmacocinética , Animales , Transporte Biológico , Glucosa/farmacocinética , Absorción Intestinal , Mucosa Intestinal/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Permeabilidad , Florizina/metabolismo
5.
Eur J Cancer ; 40(2): 245-52, 2004 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-14728939

RESUMEN

The aim of this study was to determine the diagnostic value of rectal bleeding for distal colorectal cancer (CRC), or large (> or =10 mm) adenomas among an average-risk population. A cross-sectional survey was conducted among individuals aged 55-64 years, who attended sigmoidoscopy (FS) screening in the context of a multicentre randomised trial of FS screening for CRC. Sensitivity, specificity and positive predictive value (PPV) of rectal bleeding for large distal adenomas or CRC were calculated. Rectal bleeding was reported by 8.8% of 8507 patients examined (15% of those with large adenomas and 29% of those with CRC). The risk of CRC was increased when bleeding was associated with an altered bowel habit: odds ratio (OR)=10.42; 95% Confidence Interval (CI): 4.08-26.59; the corresponding OR for isolated bleeding was 5.29 (95% CI: 2.28-12.30). Rectal bleeding carries an increased risk of distal neoplastic lesions. However, most lesions are detected among asymptomatic subjects. This finding suggests that screening represents the optimal strategy to detect CRC or large adenomas in the distal colon in the targeted age range.


Asunto(s)
Neoplasias del Colon/diagnóstico , Hemorragia Gastrointestinal/etiología , Tamizaje Masivo/métodos , Enfermedades del Recto/etiología , Neoplasias del Colon/prevención & control , Femenino , Humanos , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Factores de Riesgo
6.
Front Biosci ; 2: e108-15, 1997 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-9343490

RESUMEN

The incidence of intestinal nutrient malabsorption increases with age. Therefore, an important question is whether there are age-related changes in intestinal nutrient absorption which may contribute to a decline in absorptive capacity. Sugar and amino acid transport per mg intestine generally decreases with age. The proximate mechanism underlying this age-related decrease in transport activity is a decrease in number of transporters per mg. This reduction in transporter number can be caused by age-related changes in cell proliferation rates which, in turn, can alter the ratio of absorptive to nonabsorptive cells. The age-related change in proliferation rates typically increases intestinal mass. There seems to be no age-related changes in the steady state levels of transporter mRNA. Aging also modestly impairs the ability of intestinal nutrient transport systems to adapt to changes in dietary conditions. Caloric restriction is the only procedure known to consistently increase the lifespan of mammals. Chronic caloric restriction markedly enhances intestinal nutrient transport per mg without affecting intestinal mass. Since body weight decreases with caloric restriction, there is a dramatic increase in intestinal absorptive capacity normalized to body weight. This suggests that an increase in intestinal nutrient absorption may be a critical adaptation to caloric restriction. There is a need to perform in vivo transport studies during senescence, to distinguish between acute and chronic effects of caloric restriction, and to identify hormones that may mediate aging and caloric restriction effects on intestinal nutrient transport.


Asunto(s)
Envejecimiento/fisiología , Aminoácidos/farmacocinética , Restricción Calórica , Carbohidratos/farmacocinética , Animales , Humanos , Mucosa Intestinal/metabolismo , Longevidad , Síndromes de Malabsorción/fisiopatología , Mamíferos/fisiología , ARN Mensajero , Pérdida de Peso
7.
Radiother Oncol ; 14(1): 9-17, 1989 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-2928558

RESUMEN

Ninety-six articles published in English, French and Italian between 1938 and 1986 have been examined in order to analyze the classifications and reporting methods used by different researchers. Specialty and nationality of authors, classifications used, organs, systems and anatomic sites considered, weight given to the most frequently encountered complications are studied. Fifty-nine papers make no use of classification of complications of any kind, neither by onset time, nor by severity, but simply describe the observed events. The remaining 37 papers use a classification based on varying criteria. Thirty-four authors use a classification by severity according to different criteria; four authors classify complications according to the treatment required. In the remaining 30 papers a true scale is used. A total of 22 classifications emerges from these papers; in eight cases a previously published classification is used. The weight assigned by different authors to specific complications has been compared. The following main points emerge from the analysis: about two authors out of three simply describe the observed complications; 30 rely on a true scale of severity, but 22 different grading systems are used. Most classifications do not cover all possible complications, both surgical and radiotherapeutic, but concentrate on those complications which are typically generated by author's therapeutic approach. Only three take into account complications related to different treatment modalities. The observation period is not standardized: published data derive from follow-up times spanning from some months to many years. Authors mainly focus their interest on gastrointestinal and/or urinary complications; other organs and systems are rarely considered.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Antineoplásicos/efectos adversos , Complicaciones Posoperatorias , Radioterapia/efectos adversos , Neoplasias del Cuello Uterino/terapia , Femenino , Humanos , Metaanálisis como Asunto
8.
J Gerontol A Biol Sci Med Sci ; 52(6): B300-10, 1997 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9402931

RESUMEN

In aged, chronically calorie-restricted (CR) mice, intestinal nutrient uptake is significantly higher than in same-age ad libitum controls. Can this chronic restriction-induced enhancement of uptake be reversed by ad libitum feeding? We addressed this question by switching 32-mo-old chronically CR mice to ad libitum feeding for 4 wk (CRAL). Intestinal transport rate and total intestinal absorptive capacity for D-sugars and several nonessential L-amino acids decreased significantly in CRAL mice. In contrast, switching CR mice to an ad libitum regimen for only 3 d had no effect on intestinal nutrient transport, indicating that the negative effects of ad libitum feeding require a duration longer than the 3-d lifetime of most enterocytes. Permeability of the intestinal mucosa to L-glucose was independent of the switches in diet. Levels of the brushborder glucose transporter SGLT1, brushborder fructose transporter GLUT5, and basolateral sugar transporter GLUT2 mRNA as determined by reverse transcriptase-polymerase chain reaction in 6-, 24-, and 32-mo-old mice were each apparently independent of caloric restriction and age. We conclude that the high rates of intestinal nutrient uptake exhibited by chronically CR mice can be reversed by ad libitum feeding of only 1 mo duration. These decreases in uptake were due mainly to specific decreases in transport per unit weight of intestine and not to nonspecific decreases in intestinal mass. Changes in rates of sugar uptake induced by chronic CR and age are apparently not accompanied by changes in steady-state levels of mRNA coding for those transporters.


Asunto(s)
Envejecimiento/metabolismo , Proteínas Portadoras/genética , Ingestión de Energía , Mucosa Intestinal/metabolismo , ARN Mensajero/análisis , Aminoácidos/metabolismo , Animales , Fructosa/metabolismo , Glucosa/metabolismo , Transportador de Glucosa de Tipo 1 , Masculino , Ratones , Ratones Endogámicos C57BL , Proteínas de Transporte de Monosacáridos/análisis , Permeabilidad
9.
Clin Chim Acta ; 248(2): 175-85, 1996 Apr 30.
Artículo en Inglés | MEDLINE | ID: mdl-8740581

RESUMEN

The efficiency of bile acid conjugation before and during therapy with 600 mg/day of ursodeoxycholic acid was measured in seven adult patients with early chronic cholestatic liver disease (6 with primary biliary cirrhosis; 1 with primary sclerosing cholangitis). Duodenal bile samples were obtained by aspiration and the proportion of unconjugated bile acids was determined using lipophilic anion exchange chromatography to separate bile acid classes, followed by analysis of individual bile acids by gas chromatography-mass spectrometry. The proportion of conjugated bile acids was determined by high-performance liquid chromatography. Use of a (99m)Tc-HIDA recovery marker permitted the absolute mass of unconjugated bile acids in the gallbladder to be calculated. Unconjugated bile acids comprised 0.4% of total biliary bile acids before and 0.2% during ursodeoxycholic acid therapy, indicating highly efficient conjugation of bile acids. During therapy, percentage unconjugated ursodeoxycholic acid significantly increased from (mean +/- S.D.) 13 +/- 13% to 54 +/- 12%; P < 0.002. When the unconjugated and conjugated fractions of bile acids were compared, there was an enrichment in unconjugated fraction for cholic acid and ursodeoxycholic acid and a depletion for chenodeoxycholic acid both in basal condition and during ursodeoxycholic acid therapy, suggesting that hydrophilic bile acids were conjugated less efficiently. During therapy, the conjugation efficiency significantly increased for cholic acid and ursodeoxycholic acid. The pretreatment mass of total unconjugated bile acids in the gallbladder was (mean +/- S.D.) 4.4 +/- 3.2 mumol, and was not significantly changed by ursodeoxycholic acid therapy (6.2 +/- 3.5 mumol). However, ursodeoxycholic acid therapy caused a significant increase in the mass of unconjugated ursodeoxycholic acid. It is concluded that endogenous bile acids and exogenous ursodeoxycholic acid when given at the usual dose are efficiently conjugated in patients with early cholestatic liver disease. Despite showing increased biliary unconjugated ursodeoxycholic acid during its oral administration, our data do not lend support to the occurrence of hypercholeresis due to cholehepatic shunting of bile acids.


Asunto(s)
Ácidos y Sales Biliares/metabolismo , Colestasis Intrahepática/tratamiento farmacológico , Colestasis Intrahepática/metabolismo , Ácido Ursodesoxicólico/uso terapéutico , Adulto , Ácido Quenodesoxicólico/metabolismo , Ácido Cólico , Ácidos Cólicos/metabolismo , Cromatografía Líquida de Alta Presión , Ácido Desoxicólico/metabolismo , Vesícula Biliar/metabolismo , Cromatografía de Gases y Espectrometría de Masas , Humanos , Iminoácidos , Compuestos de Organotecnecio , Lidofenina de Tecnecio Tc 99m , Ácido Ursodesoxicólico/metabolismo
10.
Eur J Gastroenterol Hepatol ; 9(9): 881-5, 1997 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-9355787

RESUMEN

BACKGROUND: Barrett's oesophagus is a premalignant condition leading to adenocarcinoma. The incidence of adenocarcinoma of the oesophagus and the gastrooesophageal junction is rapidly increasing in the USA, northern and central Europe. Data from southern Europe are still unavailable. OBJECTIVE: To evaluate the incidence of oesophageal adenocarcinoma in a large cohort of Italian patients with Barrett's oesophagus. METHODS: A total of 344 patients (253 males and 91 females, age range 19-75 years) with histologically proven Barrett's oesophagus (length of metaplasia > or = 3 cm) were enrolled from November 1987 to June 1995. Endoscopic and histological examinations were scheduled at yearly intervals. RESULTS: One hundred and eighty-seven patients complied with the follow-up. The mean duration of the follow-up period was 36 months (total follow-up 562 patient-years; range 12-90 months). Low grade dysplasia was found in five patients at the initial examination. During the surveillance period, dysplasia increased in frequency as well as in severity and was found exclusively in the intestinal type of Barrett's oesophagus. In all, dysplastic changes were found in seven patients (five low grade and two high grade) and adenocarcinoma developed in three patients during the follow-up. In a single case, both adenocarcinoma and specialized columnar epithelium developed without any evidence of dysplasia or intestinal metaplasia at the previous follow-up examination. This prospective study shows an incidence of adenocarcinoma in Barrett's oesophagus of 1/187 patient-years. When only patients with specialized columnar epithelium were considered, the risk of adenocarcinoma was 1/88 patient-years. CONCLUSION: The present report shows that the incidence of adenocarcinoma in Italian Barrett's oesophagus patients is in the range of that reported from other Western countries.


Asunto(s)
Adenocarcinoma/epidemiología , Esófago de Barrett/epidemiología , Neoplasias Esofágicas/epidemiología , Adulto , Anciano , Estudios de Cohortes , Endoscopía , Femenino , Humanos , Italia , Masculino , Tamizaje Masivo , Persona de Mediana Edad , Estudios Prospectivos
11.
Eur J Gastroenterol Hepatol ; 12(6): 695-700, 2000 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10912491

RESUMEN

OBJECTIVE: To assess risk factors for gallstone recurrence following non-surgical treatment. DESIGN: A prospective follow-up of a multicentre cohort of post-dissolution gallstone patients. SETTING: Six gastroenterology units in the UK and Italy. PARTICIPANTS: One hundred and sixty-three patients with confirmed gallstone dissolution following non-surgical therapy (bile acids or lithotripsy plus bile acids), followed up by ultrasound scan and clinical assessment at 6-monthly intervals for up to 6 years (median, 25 months; range, 6-70 months). OUTCOME MEASURES: Subject-related variables (sex, age, height, weight, body mass index), gallstone-related variables (number, diameter, presence of symptoms, months to complete stone clearance), treatment modalities (bile acid therapy, extracorporeal shock wave lithotripsy) and follow-up related variables (weight change, use of non-steroidal anti-inflammatory agents, statins, pregnancies and/or use of oestrogens) were assessed by univariate and multivariate analysis as putative risk factors for gallstone recurrence. RESULTS: Forty-five gallstone recurrences were observed during the follow-up period. Multiple primary gallstones and length of time to achieve gallstone dissolution were the only variables associated with a significant increase in the recurrence rate. Appearance of biliary sludge during follow-up was also significantly related to development of gallstone recurrence. Use of statins or non-steroidal anti-inflammatory agents did not confer protection against recurrence. CONCLUSIONS: Patients with primary single stones are the best candidates for non-surgical treatment of gallstones, because of a low risk of gallstone recurrence. The positive association of recurrence with biliary sludge formation and time to dissolution of primary stones may provide indirect confirmation for the role of impaired gallbladder motility in the pathogenesis of this condition.


Asunto(s)
Colelitiasis/terapia , Adolescente , Adulto , Anciano , Ácido Quenodesoxicólico/uso terapéutico , Colagogos y Coleréticos/uso terapéutico , Estudios de Cohortes , Femenino , Estudios de Seguimiento , Humanos , Litotricia , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Recurrencia , Factores de Riesgo , Ácido Ursodesoxicólico/uso terapéutico
12.
J Med Screen ; 3(2): 72-8, 1996.
Artículo en Inglés | MEDLINE | ID: mdl-8849763

RESUMEN

OBJECTIVES: To assess the impact on compliance of three invitation methods, as well as the acceptability and efficacy of two bowel preparation regimens, for endoscopic screening in the general population. METHODS: 1170 subjects (men and women aged 55 to 59, in the rosters of a sample of general practitioners (GPs) in Turin), were randomly allocated to one of three invitation groups (A: personal letter, signed by GP, with a pre-fixed appointment; B: same as for A + letter supporting the study by a well known scientist; C: letter signed by the study coordinator, NS) and two preparation regimens (i: one enema, self administered at home two hours before the test; ii: two enemas, administered the night before and two hours before the test). A postal reminder was mailed to non-attenders. A sample of non-responders was contacted for a telephone interview by a trained nurse. Written consent was obtained from all subjects undergoing the test. RESULTS: A total of 278 subjects attended for sigmoidoscopic screening. An invitation from the GP alone produced the highest response rate (compliance: A = 29.3%; B = 24.9%; C = 26.8%). A single enema was as effective as two enemas in achieving satisfactory preparation for the test: the proportion of subjects invited to repeat the test was 8.1% in the single enema group, and 9.6% in the group receiving two enemas. CONCLUSIONS: Compliance with this screening procedure tends to be low. One enema, self administered two hours before sigmoidoscopy, can ensure a satisfactory bowel preparation.


Asunto(s)
Neoplasias Colorrectales/prevención & control , Tamizaje Masivo/métodos , Sigmoidoscopía , Neoplasias Colorrectales/diagnóstico , Enema/métodos , Femenino , Humanos , Italia , Masculino , Persona de Mediana Edad , Cooperación del Paciente , Negativa del Paciente al Tratamiento
13.
Surg Endosc ; 17(4): 539-42, 2003 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12582755

RESUMEN

BACKGROUND: Barrett's esopagus (BE) is considered a risk factor for the development of esophageal carcinoma. Recently, partial restoration of squamous mucosa after ablation of BE with endoscopic techniques has been described. METHODS: From November 1996 to November 1999, 23 patients with histologically proven BE have been treated by endoscopic argon plasma coagulation (APC) following suppression of gastro-esophageal reflux by laparoscopic fundoplication. Histological follow-up after completed ablation ranged from 16 to 45 months (mean, 31.9 months). RESULTS: Histologically, complete squamous reepithelialization was observed in 20/23 patients, whereas a regrowth of a mixed squamous and gastric type mucosa was observed in 1 patient. Small islands of intestinal metaplasia were observed under the neosquamous epithelium in two patients (9%) during follow-up. CONCLUSION: The success rate of APC ablation following laparoscopic antireflux surgery in our series may be as high as 91%. Nevertheless, small islands of intestinal metaplasia under the new squamous epithelium may persist in some patients. In these circumstances, the authors recommend that endoscopic ablation of BE should be confined to controlled clinical trials.


Asunto(s)
Esófago de Barrett/cirugía , Coagulación con Láser , Adulto , Anciano , Argón , Esófago de Barrett/complicaciones , Esófago de Barrett/patología , Endoscopía , Femenino , Fundoplicación , Reflujo Gastroesofágico/complicaciones , Reflujo Gastroesofágico/cirugía , Humanos , Laparoscopía , Masculino , Persona de Mediana Edad , Resultado del Tratamiento
14.
Hepatogastroenterology ; 48(41): 1346-50, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11677961

RESUMEN

BACKGROUND/AIMS: To identify subgroups of patients at high risk of local relapse after curative surgery for rectal cancer. METHODOLOGY: Thirty-five variables of 216 patients observed from January 1987 to December 1995 were retrospectively analyzed according to univariate and multivariate methods. Median follow-up was 38 months. RESULTS: High and moderate grade (P = 0.0001), Size > or = 5 cm (P = 0.013), lymph nodes involvement (P = 0.002) and patients with locally advanced rectal cancer underwent extensive surgery and postoperative radiation significantly increased local relapse; whereas surgical procedure and experience of surgeons had no influence. CONCLUSIONS: The above-mentioned prognostic factors of rectal cancer that show a risk of local relapse 2- to 3.5-times higher than comparative conditions could be useful in identifying subgroups of patients at high risk for local recurrence. These patients should undergo a careful selection according to risk factors of relapse in order to increase local control of disease performing "optimal" primary surgery, effective postoperative radiation and tailored follow-up.


Asunto(s)
Adenocarcinoma/cirugía , Recurrencia Local de Neoplasia/cirugía , Neoplasias del Recto/cirugía , Adenocarcinoma/patología , Adenocarcinoma/radioterapia , Anciano , Terapia Combinada , Femenino , Humanos , Metástasis Linfática , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia/patología , Recurrencia Local de Neoplasia/radioterapia , Estadificación de Neoplasias , Pronóstico , Radioterapia Adyuvante , Neoplasias del Recto/patología , Neoplasias del Recto/radioterapia , Reoperación , Riesgo
15.
Tumori ; 74(3): 275-9, 1988 Jun 30.
Artículo en Inglés | MEDLINE | ID: mdl-3400118

RESUMEN

Inter-observer agreement was tested in the interpretation by 8 radiologists of mammograms from 45 women (for a total of 180 films per radiologist). The radiologists were representative of the whole range of those involved in mammography in the town of Torino, with a number of films read per year ranging from 100 to 4000. Out of the 45, 9 women were affected by breast cancer (histologically proved), 25 had benign disease (diagnosed with fine-needle aspiration) and 11 had normal breasts. Weighted kappa values were in the range 0.27-0.82 (median 0.60) for parenchymal patterns; 0.33-0.67 (0.48) for diagnosis in five categories; and 0.22-0.57 (0.38) for indications for further diagnostic tests. These values are comparable with those reported from other investigations.


Asunto(s)
Neoplasias de la Mama/prevención & control , Mamografía/normas , Tamizaje Masivo/normas , Femenino , Humanos , Control de Calidad
16.
Minerva Med ; 73(5): 171-4, 1982 Feb 11.
Artículo en Italiano | MEDLINE | ID: mdl-7063133

RESUMEN

Results obtained by using Angelchik and Cohen's ring prosthesis in 10 patients with hernia due to sliding through the oesophageal hiatus of the diaphragm are reported. In 8 patients, the ring was perfectly tolerated and performed its antireflux and hernia containment functions. In the 2 other patients, however, the prosthesis rose to the mediastinum, causing hernia to recur in one case and leading to recurrence of symptomatology in the other.


Asunto(s)
Reflujo Gastroesofágico/terapia , Hernia Diafragmática/terapia , Hernia Hiatal/terapia , Prótesis e Implantes , Adulto , Anciano , Femenino , Humanos , Masculino
17.
Minerva Med ; 77(1-2): 1-5, 1986 Jan 14.
Artículo en Italiano | MEDLINE | ID: mdl-3080713

RESUMEN

The complex diagnostic procedure involved in a case of splenic abscess in a young drug addict as a result of septicaemia caused by streptococcus fascalis is described and discussed with an examination of the criteria in support of a more aggressive approach to the removal of septic foci in such patients with AIDS. It is concluded that such criteria are valid even when, as in the case described, splenectomy further depresses the immune system.


Asunto(s)
Absceso/etiología , Síndrome de Inmunodeficiencia Adquirida/complicaciones , Dependencia de Heroína/complicaciones , Enfermedades del Bazo/etiología , Infecciones Estreptocócicas/etiología , Absceso/diagnóstico , Absceso/diagnóstico por imagen , Adulto , Enterococcus faecalis , Femenino , Humanos , Enfermedades del Bazo/diagnóstico , Infecciones Estreptocócicas/diagnóstico , Tomografía Computarizada por Rayos X
18.
Minerva Gastroenterol Dietol ; 38(4): 197-206, 1992.
Artículo en Italiano | MEDLINE | ID: mdl-1296778

RESUMEN

The availability of the gamma-labelled bile acid 75SeHCAT, that allows a non-invasive assessment of the enterohepatic circulation of bile acids, has prompted in the last 10 years the implementation of several studies involving wide series of normal subjects and patients with various organic and functional bowel disorders. The clinical indications for performing a SeHCAT test have been clearly defined: the test can identify with high accuracy, in the setting of the irritable bowel syndrome, the patients with bile acid malabsorption that can be confidently and successfully treated with cholestyramine; it can also assess whether, and to what extent, the diarrhoea presenting in patients with intestinal organic disorders is due to bile acid malabsorption, permitting an optimal therapeutic strategy to be designed. The parameters of the hepatic handling of SeHCAT after bolus intravenous administration have been characterized in normals, and studies on various chronic hepatic disorders are now in progress. Interesting results are emerging from studies performed in patients with chronic non-obstructive cholestatic disease, where a specific defect in the excretion rate of SeHCAT is present: these studies may cast more light on the abnormalities of bile secretion and on the mechanism of action of drugs used to treat this condition, forming the rationale for the use of intravenous SeHCAT for hepatobiliary dynamic scintigraphy as a sophisticated liver function test. In conclusion, the SeHCAT test has become an important diagnostic tool for the gastroenterologist studying the diarrhoea, and awaits more studies to be used also by the hepatologist. The relatively long physical half-life of 75Se (180 days), preventing a wider use of the test, could theoretically be overcome by the synthesis of a similar gamma-labelled bile acid with a shorter half-life.


Asunto(s)
Ácidos y Sales Biliares/fisiología , Radioisótopos de Selenio , Ácido Taurocólico/análogos & derivados , Circulación Enterohepática , Humanos , Absorción Intestinal , Síndromes de Malabsorción/diagnóstico por imagen , Síndromes de Malabsorción/fisiopatología , Cintigrafía , Radioisótopos de Selenio/farmacocinética , Ácido Taurocólico/farmacocinética
19.
Minerva Med ; 76(38): 1719-26, 1985 Oct 06.
Artículo en Italiano | MEDLINE | ID: mdl-3876522

RESUMEN

Results obtained in the control of oesophageal varix rupture haemorrhage by intravenous vasopressin perfusion or selective intraarterial administration are reported. This comparative study shows intravenous administration to be the best method since it produces the same therapeutic effects with fewer undesirable side-effects than when administered arterially. In view of the high level of complications caused by selective arterial catheters, this administration method would only appear justified in cases where selective arterial catheterisation is to be carried out in any case.


Asunto(s)
Várices Esofágicas y Gástricas/tratamiento farmacológico , Hemorragia Gastrointestinal/tratamiento farmacológico , Inyecciones Intravenosas , Vasopresinas/administración & dosificación , Adulto , Anciano , Arritmias Cardíacas/inducido químicamente , Femenino , Hemorragia Gastrointestinal/mortalidad , Humanos , Hipertensión/inducido químicamente , Inyecciones Intraarteriales , Masculino , Persona de Mediana Edad , Vasopresinas/efectos adversos
20.
Minerva Med ; 80(11): 1163-78, 1989 Nov.
Artículo en Italiano | MEDLINE | ID: mdl-2513534

RESUMEN

On the basis of personal experience and the latest reports in the literature on the treatment of short bowel syndrome, the clinical and therapeutic aspects of the malabsorption syndrome arising after removal of long segments of the small intestine are analysed with emphasis on the salient features and particularly the critical phase constituted by the transfer from parenteral to enteral and oral nutrition whose importance for the maintenance of life is objectively confirmed by the adaptive response of the remaining small bowel (compensatory hypertrophy).


Asunto(s)
Síndromes de Malabsorción/terapia , Síndrome del Intestino Corto/terapia , Adaptación Fisiológica , Adulto , Anciano , Nutrición Enteral , Femenino , Alimentos Formulados , Humanos , Hipertrofia , Intestino Delgado/fisiopatología , Intestino Delgado/cirugía , Masculino , Persona de Mediana Edad , Síndrome del Intestino Corto/fisiopatología , Síndrome del Intestino Corto/cirugía , Vitaminas/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA